Ask the Experts: Considerations for Nanoparticle Therapeutics
Join a panel of experts as they discuss nanoparticle technology and key considerations for nanoparticle-based drug delivery.
regulatory
Moving against mucopolysaccharidosis
EMA grants Orphan Drug designation to JR-171 for the treatment of mucopolysaccharidosis type I
CNS therapy trio gains Fast Track
FDA grants Fast Track designations to three of Passage Bio’s gene therapy candidates for CNS disorders
